After reaching stable status, cells were treated with metformin (0 and 5 mmol/L). After 8 h of treatment, cells were collected and used for flow cytometry and mRNA transcriptome sequencing (method described above). Upon establishment of Hashimoto’s thyroiditis animal model and completion of metformin intervention (within 30 min before sacrifice), mice were grabbed and their abdomens were gently massaged to stimulate defecation.

August 26, 2024 - In a 12-week study of patients with Hashimoto’s thyroiditis, all patients were given metformin 500 mg twice a day for a period of one week, and then the dose was increased to 1,000 mg twice a day for the remaining eleven weeks.

Conclusion: Metformin significantly reduces TPOAb level and TgAb level in patients with HT and SH, especially TPOAb. This study is the first to provide a preliminary theoretical basis for the clinical application of metformin in the treatment of HT.

May 5, 2021 - After reaching stable status, cells were treated with metformin (0 and 5 mmol/L). After 8 h of treatment, cells were collected and used for flow cytometry and mRNA transcriptome sequencing (method described above). Upon establishment of Hashimoto’s thyroiditis animal model and completion of metformin intervention (within 30 min before sacrifice), mice were grabbed and their abdomens were gently massaged to stimulate defecation.

Metformin significantly reduced TPOAb levels and TgAb levels in patients with HT and SH, especially TPOAb (HT: p TPOAb = .009, p TgAb = .046; SH: p TPOAb = .034, p TgAb = .066). In addition, metformin also reduced the levels of thyroid stimulating hormone (TSH), homeostasis model assessment of insulin resistance (HOMA-IR) in patients with HT and SH (HT: p TSH = .000 and p HOMA-IR = .000; SH: p TSH = .000 and p HOMA-IR = .000, respectively).

February 17, 2021 - Findings: We found that metformin indeed has a therapeutic effect on mice with HT mainly by reducing TgAb and lymphocyte infiltration in thyroid tissue. In addition, metformin also significantly inhibits the formation of Th17 cells and M1 ...

September 20, 2022 - Metformin exerts an inhibitory effect on AMPK activity in the hypothalamus, where it opposes T3 [40]. Additionally, evidence demonstrates that insulin resistance can have a role in the link between metformin and TSH. In a four-month pilot study, metformin treatment led to a reduction in TSH in patients with interferon-induced hypothyroidism, more pronounced than in patients with Hashimoto’s thyroiditis [41]. Nevertheless, its clinical significance is still unknown.

June 24, 2023 - Metformin has been found to reduce elevated gonadotropin levels. Hashimoto’s thyroiditis is the most common thyroid disorder in iodine-sufficient areas, and it often develops in postmenopausal women.

May 28, 2021 - Interpretation: These experiments provided a preliminary theoretical basis for the clinical application of metformin in the treatment of HT. Keywords: Hashimoto’s thyroiditis; Th17 cells; immune; intestinal flora; metformin.

November 15, 2024 - Metformin: A Potential Candidate for Targeting Aging Mechanisms. Aging Dis. 2021;12(2):480-493. Published 2021 Apr 1. doi:10.14336/AD.2020.0702 [4] Jia X, Zhai T, Zhang JA. Metformin reduces autoimmune antibody levels in patients with Hashimoto’s thyroiditis: A systematic review and meta-analysis.

October 31, 2013 - Metformin is a biguanide derivative oral drug used for treatment of T2DM and is commonly regarded as safe drug with no clinically relevant side effect and drug interaction with exception of folate and vitamin B12 [7]. In recent years few studies have shown TSH suppressive effect of metformin ...

December 5, 2023 - In women with autoimmune thyroiditis, ... in other groups of hypothyroid women, metformin may activate hypothalamic–pituitary–thyroid axis activity directly at the level of thyrocytes....

September 12, 2022 - While there is currently no cure for Hashimoto’s thyroiditis, levothyroxine can regulate your hormones and restore your metabolism. A study⁵ in 2021 showed that metformin could reverse Hashimoto’s, but the researchers admit it’s a small-scale study with limitations.

August 1, 2020 - Metformin inhibits the secretory function of overactive anterior pituitary cells, including lactotropes. In women of childbearing age, this effect was absent if they had coexisting autoimmune (Hashimoto) thyroiditis.

June 23, 2024 - This study suggests that metformin may help stabilize thyroid function in these patients. Improvement in Metabolic Parameters: A study by Liu et al. (2015) evaluated the effects of metformin on metabolic parameters in patients with hypothyroidism and insulin resistance.

April 1, 2017 - Individuals with hyperinsulinemia ... and cancer. Accordingly, patients treated with metformin have a smaller thyroid volume and a lower risk of incident goiter, thyroid nodule and cancer....

July 12, 2024 - In particular, studies have shown that metformin may slightly increase thyroid hormone (TSH) levels, keeping them within the normal range. Metformin reduces glucose production in the liver and improves insulin sensitivity in the body.

May 28, 2021 - The results of mRNA sequencing of thyroid · tissue illustrated that the therapeutic effect of metformin on HT was mainly achieved by · regulating immune pathways. 16S RNA sequencing of the intestinal flora found that the · intestinal flora of HT mice differs significantly from that of the normal mice and also were ... Frontiers in Cell and Developmental Biology | www.frontiersin.org 1May 2021 | Volume 9 | Article 685522 ... Jia et al. Metformin Reverses Hashimoto’s Thyroiditis